Cargando…
The Performances of Three Commercially Available Assays for the Detection of SARS-CoV-2 Antibodies at Different Time Points Following SARS-CoV-2 Infection
The aim of this study was to evaluate the performances of three commercially available antibody assays for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies at different time points following SARS-CoV-2 infection. Sera from 536 cases, including 207 SARS-CoV-2 P...
Autores principales: | Syre, Heidi, Obreque, Marius Eduardo Brå, Dalen, Ingvild, Riis, Åse Garløv, Berg, Åse, Löhr, Iren Høyland, Sundal, Jon, Kleppe, Lars Kåre, Vadla, May Sissel, Lenning, Ole Bernt, Olofsson, Jan Stefan, Mohn, Kristin Greve-Isdahl, Tøndel, Camilla, Blomberg, Bjørn, Trieu, Mai Chi, Langeland, Nina, Cox, Rebecca Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610468/ https://www.ncbi.nlm.nih.gov/pubmed/36298751 http://dx.doi.org/10.3390/v14102196 |
Ejemplares similares
-
Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers
por: Bansal, Amit, et al.
Publicado: (2023) -
Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022) -
Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021) -
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021) -
SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)